Skip to Content
U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine
Last Updated: 04/25/2012


Food and Drug Administration

CDP has monthly meetings with the Center for Diagnostics and Regulatory Health at FDA and the DCTD Cancer Therapy Evaluation Program at which markers/assays proposed for clinical trials are discussed. In addition, appropriate regulatory issues for multi-analyte assays, such as genomics, are also discussed in order to understand issues that could impede development of these assays.